Two of the new cases were fatal, and the WHO reports on a 3-person family cluster in Saudi Arabia.
Health officials in the Philippines reported a case of MERS in a Filipino nurse who recently returned from Saudi Arabia, according to a Reuters story today.
The nurse returned to the Philippines last week and presented with a fever, body pain, cough, and difficulty breathing. She was diagnosed with MERS-CoV (Middle East respiratory syndrome coronavirus) and is currently hospitalized in stable condition, the story said.
As Saudi Arabia reports 2 new cases, the WHO discusses inadequate hospital infection control measures.
Saudi Arabia's Ministry of Health (MOH) reported four new MERS cases and one death in the past 2 days, bringing the country's total to 855 cases since June 2012. The country has confirmed 10 cases in the past 5 days.
California officials yesterday confirmed 7 new measles cases in an outbreak that began in December, bringing the case total for the state to 99, while 5 babies at a Chicago-area daycare have also been diagnosed as having the disease.
Also yesterday, the Trust for America's Health (TFAH) pointed out the states having the lowest measles vaccination coverage in toddlers.
The newly reported patients are from Al-Kharj and Hofuf, and the WHO notes 9 previously reported cases.
California officials today said they have confirmed 92 measles cases since December, 59 of which are linked to visiting Disneyland, bringing the US total to more than 100 cases, while Toronto has confirmed 4 cases not linked to each other or to travel outside the country.
Two men have been stricken with MERS-CoV in Saudi Arabia, bringing the total case count since June 2012 to 845, according to an update today from the country's ministry of health (MOH).
The world is "dangerously unpreprepared" for future pandemics, and a private-public sector proposal that includes a pandemic facility and insurance coverage could help countries across the globe mitigate the risk, World Bank President Jim Yong Kim said today in a speech at Georgetown University.
The US Food and Drug Administration (FDA) today approved Bexsero, a Novartis vaccine to prevent meningococcal disease caused by Neisseria meningitidis serogroup B in people 10 through 25 years, the second group B vaccine approved by the FDA.
